Type A botulinum toxin in the upper aspect of the face

Clinics in Dermatology

Volumn 21, Issue 6, 2003, Pages 488-497

  Hexsel, Dóris ^a   Dal'Forno, Taciana ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANESTHETIC AGENT; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; PENICILLAMINE; QUININE;

CLINICAL TRIAL; DIPLOPIA; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG UPTAKE; DYSTONIA; ECCHYMOSIS; ECTROPION; ERYTHEMA; EYELID DISEASE; FACE; FACE ASYMMETRY; FACE EDEMA; FACE MUSCLE; FACE PAIN; FACE SURGERY; FACIAL EXPRESSION; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERHIDROSIS; HYPERKINESIA; INJECTION PAIN; KERATITIS; LOW DRUG DOSE; MUSCLE ATROPHY; MUSCLE HYPERTROPHY; MUSCLE WEAKNESS; NAUSEA; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; PTOSIS; REVIEW; SIDE EFFECT; SWEATING; TENSION HEADACHE; WOUND HEALING; WRINKLE;

EID: 0842283508     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2003.11.002     Document Type: Article

References (66)

1. Carruthers J.D.A., Carruthers J.A. Treatment of glabellar frown lines with C botulinum-A exotoxin. J Dermatol Surg Oncol. 18:1992;17-21.
2. Carruthers A., Carruthers J. History of the cosmetic use of botulinum A exotoxin. Dermatol Surg. 24:1998;1168-1170.
3. Carruthers A. Botulinum toxin type A history and current cosmetic use in the upper face . Dis Mon. 48:2002;299-322.
4. Matarasso S.L. Comparison of botulinum toxin types A and B a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides . Dermatol Surg. 29:2003;7-13.
5. Glogau R.G. Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes. Clin J Pain. 18:2002;191-197.
6. Sadick N.S. Botulinum toxin type B for glabellar wrinkles a prospective open-label response study . Dermatol Surg. 28:2002;817-821.
7. Barnes M.P. Practical aspects of using botulinum toxin type B. Eur J Neurol. 8:2001;19-21.
8. O'Brien CF. The clinical le of Elan Pharmaceuticals' botulinum toxin type B. Eur J Neurology 2001;8:13-7.
9. Brashear A., McAfee A.L., Kuhn E.R., et al. Treatment with botulinum toxin type B for upper-limb spasticity. Arch Phys Med Rehabil. 84:2003;103-107.
10. Baumann L.S., Halem M.L. Systemic adverse effects after botulinum toxin type B (Myobloc) injections for the treatment of palmar hyperhidrosis. Arch Dermatol. 139:2003;226-227.
11. Dressles D., Benecke R. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol. 49:2003;34-38.
12. Carruthers J.A., Lowe N.J., Menter M.A., et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 46:2002;840-849.
13. Lowe N.J., Lask G., Yamauchi P., et al. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet. J Am Acad Dermatol. 47:2002;834-840.
14. Keen M., Blitzer A., Aviv J., et al. Botulinum toxin A for hyperkinetic facial lines results of a double-blind, placebo-controlled study . Plast Reconstruct Surg. 94:1994;94-99.
15. Lowe N.J., Maxwell A., Harper H. Botulinum A exotoxin for glabellar folds a double-blind, placebo-controlled study with na electromyographic injection technique . J Am Acad Dermatol. 35:1996;569-572.
16. Klein A.W. Treatment of wrinkles with Botox® Kreyden O.P., Böni R., Burg G. Hyperhidrosis and botulinum toxin in dermatology. Current problems in dermatology. 30:2002;188-217 Karger, Basel.
17. Naoum C., Dasiou-Plakita D. Dermal filler materials and botulin toxin. Int J Dermatol. 40:2001;609-621.
18. Carruthers A., Carruthers J. Cosmetic uses of botulinum A exotoxin. Adv Dermatol. 12:1997;325-348.
19. Sommer B., Lowe N. Cosmetic indications. Moore P., Naumann M. Handbook of botulinum toxin treatment. 2th ed :2003;422-437 Blackwell Science, Oxford.
20. Wieder J.M., Moy R.L. Understanding botulinum toxin surgical anatomy of the frown, forehead and periocular region . Dermatol Surg. 24:1998;1172-1174.
21. Benedetto A.V. The cosmetic uses of botulinum toxin type A. Int J Dermatol. 38:1999;641-655.
22. Carruthers A., Carruthers J. Botulinum toxin type A history and current cosmetic use in the upper face . Semin Cutan Med Surg. 20:2001;71-84.
23. Garcia A., Fulton J.E. Cosmetic denervation of the muscles of facial expression with botulinum toxin. Dermatol Surg. 22:1996;39-43.
24. Tan S.R., Solish N. Long-term efficacy and quality of life in the treatment of focal hyperhidrosis with botulinum toxin A. Dermatol Surg. 28:2002;495-499.
25. Kinkelin I., Hund M., Naumann M., et al. Effective treatment of frontal hyperhidrosis with botulinum toxin A. Br J Dermatol. 143:2000;824-827.
26. Louarn C.L. Botulinum toxin A and facial lines the variable concentration . Aesthet Plast Surg. 25:2001;73-84.
27. Hexsel D, Almeida AT, Rutowitch MS, et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin A reconstituted in 6 consecutive weeks prior to application. Dermatol Surg 2003;29:523-529.
28. Lowe N.J. Botulinum toxin type A for facial rejuvenation United States and United Kingdom perspectives . Dermatol Surg. 24:1998;1216-1218.
29. Sampaio C., Ferreira J.J., Simoes F., et al. DYSBOT a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A, Dysport and Botox, assuming a ratio 4:1 . Mov Disord. 12:1997;1013-1018.
30. Moraru E., Voller B., Auff E., et al. Dose thresholds and local anhidrotic effect of botulinum A toxin injections (Dysport). Br J Dermatol. 145:2001;368.
31. Klein A.W., Mantell A. Electromyographic guidance in injecting botulinum toxin. Dermatol Surg. 24:1998;1184-1186.
32. Edelstein C., Shorr N., Jacobs J., et al. Oculoplastic experience with the cosmetic use of botulinum A exotoxin. Dermatol Surg. 24:1998;1208-1212.
33. Khawaja H.A., Hernandez-Perez E. Botox in dermatology. Int J Dermatol. 40:2001;311-317.
34. Matarasso S.L., Matarasso A. Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lipptosis following injections to the lateral canthal rhytids. Plast Reconstr Surg. 108:2001;208-217.
35. Carruthers J., Carruthers A. Botox treatment for expressive facial lines and wrinkles. Curr Opin Otolaryngol Head Neck Surg. 8:2000;357-361.
36. Carruthers J., Carruthers A. Botulinum toxin (Botox) chemodenervation for facial rejuvenation. Facial Plast Surg. 9:2001;197-204.
37. Carruthers A., Carruthers J. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin. Dermatol Surg. 24:1998;1189-1194.
38. Carruthers A., Kiene K., Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Dermatol. 34:1996;788-797.
39. Hankins C.L., Strimling R., Rogers G.S. Botulinum A toxin for glabellar wrinkles dose response . Dermatol Surg. 11:1998;1183-1187.
40. Carruthers JA, Lowe NJ, Menter MA, et al. One year, two-period study of the safety and efficacy of botulinum toxin type A in patients with glabellar lines. Presented at the American Academy of Dermatology, Washington, DC., 2001.
41. Hexsel D, Mazzuco R, Zechmeister M, et al. Complications and adverse affects: diagnosis and treatment. In: Hexsel D, Almeida AT, eds. Cosmetic use of botulinum toxin. 1st ed. Porto Alegre, Brazil: AGE, 2002:233-9.
42. Klein A.W. Complications and adverse reactions with the use of botulinum toxin. Semin Cutan Med Surg. 2:2001;109-120.
43. Huilgol S.C., Carruthers A., Carruthers J.D.A. Raising eyebrows with botulinum toxin. Dermatol Surg. 25:1999;373-376.
44. Huang W., Rogachefsky A.S., Foster J.A. Browlift with botulinum toxin. Dermatol Surg. 26:2000;55-60.
45. Kokoska M.S., Amato J.B., Hollenbeak C.S., et al. Modifications of eyebrow position with botulinum exotoxin A. Arch Facial Plast Surg. 4:2002;244-247.
46. Edelstein C., Shorr N., Jacobs J., et al. Oculoplastic experience with the cosmetic use of botulinum A exotoxin. Dermatol Surg. 24:1998;1208-1212.
47. Blitzer A., Binder W.J., Aviv J.E. The management of hyperfunctional facial lines with botulinum toxin. Arch Otolaryngol Head Neck Surg. 123:1997;389-392.
48. Tambasco N., Lalli F., Mancini M.L., et al. Botulinum toxin in the treatment of facial expression wrinkles (ITA). Riv Ital Chir Plast. 29:1997;197-200.
49. Flynn T.C., Carruthers J.A., Carruthers J.A. Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatol Surg. 27:2001;703-708.
50. Wollina U. Botulinum A toxin for wrinkles release from tension headache . J Eur Acad Dermatol Venereol. 14:2000;142-143. (Letter).
51. Böger A., Herath H., Rompel R., et al. Botulinum toxin for treatment of craniofacial hyperhidrosis. J Neurol. 415:2000;857-861.
52. Hexsel D, Zechmeister M, Zechmeister D, Dal'Forno T. Avaliation of the diffusion of the botulinum toxin. In: Hexsel D, Almeida AT (eds). Hyperhidrosis and Botulinum Toxin. Authors' edition. São Paulo, 2003:145-151.
53. Gassner H.G., Sherris D.A., Otley C.C. Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates. Plast Reconstr Surg. 105:2000;1948-1955.
54. Hexsel D. Combining procedures with botulinum toxin in dermatology and dermatological surgery. Hexsel D., Almeida A.T. Cosmetic use of botulinum toxin. 1st ed :2002;211-215 AGE, Porto Alegre, Brazil.
55. Pinski J.B., Roenigk H.H. Botox clinical aspects . Dermatol Ther. 13:2000;198-200.
56. Markey A.C. Botulinum A exotoxin in cosmetic dermatology. Clin Exp Dermatol. 25:2000;173-175.
57. Carruthers A., Carruthers J. The adjunctive usage of botulinum toxin. Dermatol Surg. 24:1998;1244-1247.
58. Bulstrode N.W., Grobbelar A.O. Long-term prospective follow-up of botulinum toxin treatment for facial rhytides. Aesthet Plast Surg. 26:2002;356-359.
59. Hexsel D., Hexsel C.L., Bohn J. Long, mid, and short term effects of botulinum toxin on the musculature. Hexsel D., Almeida A.T. Cosmetic use of botulinum toxin. 1st ed :2002;99-103 AGE, Porto Alegre, Brazil.
60. Hexsel D, Dal'Forno T, Hexsel CL. Complicações no uso da toxina botulínica. In: Almeida AT, Hexsel D, eds. Hiperidrose e toxina botulínica. (In press).
61. Sadick N.S. Overview of complications of nonsurgical facial rejuvenation procedures. Clin Plast Surg. 1:2001;163-176.
62. Alam M., Dover J.S., Arndt K.A. Pain associated with injec-tion of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative a double-blind, randomized controlled trial . Arch Dermatol. 138:2002;510-514.
63. Becker D.S. Muscle recruitment as a potential side effect of botulinum toxin therapy. Cosmet Dermatol. 15:2002;35-36.
64. Matarasso S.L. Complications of botulinum A exotoxin for hyperfunctional lines. Dermatol Surg. 24:1998;1249-1254.
65. Ahn K.Y., Park M.Y., Park D.H., et al. Botulinum toxin A for the treatment of crow's feet. Plast Reconstr Surg. 105:2000;778-784.
66. Matarasso S.L. Perioral asymmetry following botulinum toxin treatment of the ocular canthus. Cosmet Dermatol. 15:2002;25-26.